Korea's Celltrion In Deal With U.S.-based Hospira For Biogeneric Sales; M&A Hinted At

SEOUL - South Korea's Celltrion inked an agreement with U.S.-based Hospira to collaborate on manufacturing and marketing Celltrion's eight biogeneric products in global markets including the U.S. and Europe